Td Asset Management Inc Keros Therapeutics, Inc. Transaction History

Td Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$31.57 - $43.02 $571,417 - $778,662	18,100 Added 100.0%	36,200 $1.15 Million
Q1 2023 May 10, 2023	BUY	$41.44 - $59.32 $335,664 - $480,492	8,100 Added 81.0%	18,100 $772,000
Q4 2022 Feb 06, 2023	BUY	$39.45 - $51.77 $394,500 - $517,700	10,000 New	10,000 $480,000

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $408M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.